{ "meta": { "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.", "terms": "https://open.fda.gov/terms/", "license": "https://open.fda.gov/license/", "last_updated": "2026-01-27", "results": { "skip": 0, "limit": 1, "total": 52302 } }, "results": [ { "safetyreportversion": "1", "safetyreportid": "10006258", "primarysourcecountry": "US", "occurcountry": "US", "transmissiondateformat": "102", "transmissiondate": "20141002", "reporttype": "1", "serious": "1", "seriousnessdeath": "1", "receivedateformat": "102", "receivedate": "20140313", "receiptdateformat": "102", "receiptdate": "20140313", "fulfillexpeditecriteria": "1", "companynumb": "US-NOVOPROD-402211", "duplicate": "1", "reportduplicate": { "duplicatesource": "NOVO NORDISK", "duplicatenumb": "US-NOVOPROD-402211" }, "primarysource": { "reportercountry": "US", "qualification": "4" }, "sender": { "sendertype": "2", "senderorganization": "FDA-Public Use" }, "receiver": { "receivertype": "6", "receiverorganization": "FDA" }, "patient": { "patientsex": "1", "reaction": [ { "reactionmeddraversionpt": "17.0", "reactionmeddrapt": "Pancreatic carcinoma", "reactionoutcome": "5" } ], "drug": [ { "drugcharacterization": "1", "medicinalproduct": "VICTOZA", "drugbatchnumb": "UNKNOWN", "drugauthorizationnumb": "022341", "drugdosagetext": "UNK", "drugdosageform": "SOLUTION FOR INJECTION", "drugadministrationroute": "058", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "drugstartdateformat": "602", "drugstartdate": "2010", "drugenddateformat": "610", "drugenddate": "201201", "actiondrug": "1", "openfda": { "application_number": [ "NDA022341" ], "brand_name": [ "VICTOZA" ], "generic_name": [ "LIRAGLUTIDE" ], "manufacturer_name": [ "Novo Nordisk" ], "product_ndc": [ "0169-4060" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "SUBCUTANEOUS" ], "substance_name": [ "LIRAGLUTIDE" ], "rxcui": [ "897122", "897126" ], "spl_id": [ "0d10d10e-0fe0-47ee-b9da-628e34907e98" ], "spl_set_id": [ "5a9ef4ea-c76a-4d34-a604-27c5b505f5a4" ], "package_ndc": [ "0169-4060-13", "0169-4060-12", "0169-4060-90", "0169-4060-97", "0169-4060-98", "0169-4060-99" ], "nui": [ "N0000178480", "M0160181", "N0000020058" ], "pharm_class_epc": [ "GLP-1 Receptor Agonist [EPC]" ], "pharm_class_cs": [ "Glucagon-Like Peptide 1 [CS]" ], "pharm_class_moa": [ "Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]" ], "unii": [ "839I73S42A" ] } }, { "drugcharacterization": "1", "medicinalproduct": "JANUVIA", "drugdosagetext": "UNK", "drugadministrationroute": "048", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "drugstartdateformat": "602", "drugstartdate": "2010", "drugenddateformat": "610", "drugenddate": "201201", "actiondrug": "1", "openfda": { "application_number": [ "NDA021995" ], "brand_name": [ "JANUVIA" ], "generic_name": [ "SITAGLIPTIN" ], "manufacturer_name": [ "Merck Sharp & Dohme LLC" ], "product_ndc": [ "0006-0112", "0006-0221", "0006-0277" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "SITAGLIPTIN PHOSPHATE" ], "rxcui": [ "665036", "665040", "665044", "2709603", "2709608", "2709612" ], "spl_id": [ "71d449de-955b-4711-9a44-1e1f66e2e9eb" ], "spl_set_id": [ "f85a48d0-0407-4c50-b0fa-7673a160bf01" ], "package_ndc": [ "0006-0221-01", "0006-0221-28", "0006-0221-31", "0006-0221-54", "0006-0112-01", "0006-0112-28", "0006-0112-31", "0006-0112-54", "0006-0277-01", "0006-0277-28", "0006-0277-31", "0006-0277-54", "0006-0277-02", "0006-0277-33", "0006-0277-82", "0006-0277-14", "0006-0277-27", "0006-0277-30" ], "unii": [ "TS63EW8X6F" ] } }, { "drugcharacterization": "1", "medicinalproduct": "JANUMET", "drugdosagetext": "UNK", "drugadministrationroute": "048", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "drugstartdateformat": "602", "drugstartdate": "2010", "drugenddateformat": "610", "drugenddate": "201201", "actiondrug": "1", "openfda": { "application_number": [ "NDA022044", "NDA202270" ], "brand_name": [ "JANUMET", "JANUMET XR" ], "generic_name": [ "SITAGLIPTIN AND METFORMIN HYDROCHLORIDE" ], "manufacturer_name": [ "Merck Sharp & Dohme LLC" ], "product_ndc": [ "0006-0575", "0006-0577", "0006-0078", "0006-0080", "0006-0081" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "METFORMIN HYDROCHLORIDE", "SITAGLIPTIN PHOSPHATE" ], "rxcui": [ "861771", "861821", "2709488", "2709491", "1243833", "1243843", "1243848", "2709470", "2709477", "2709482" ], "spl_id": [ "601dfad8-02f7-4696-9fe2-548610338dc9", "4323fb1c-54a7-4648-bfe0-28fb4cb65f50" ], "spl_set_id": [ "d19c7ed0-ad5c-426e-b2df-722508f97d67", "64beb3d2-3aeb-4cd5-ba11-dacf6c9a5b50" ], "package_ndc": [ "0006-0575-82", "0006-0575-61", "0006-0575-62", "0006-0575-01", "0006-0575-52", "0006-0575-56", "0006-0575-02", "0006-0575-03", "0006-0577-61", "0006-0577-62", "0006-0577-82", "0006-0577-01", "0006-0577-52", "0006-0577-56", "0006-0577-02", "0006-0577-03", "0006-0078-61", "0006-0078-62", "0006-0078-82", "0006-0078-14", "0006-0078-28", "0006-0080-61", "0006-0080-62", "0006-0080-82", "0006-0080-14", "0006-0080-28", "0006-0081-31", "0006-0081-54", "0006-0081-82", "0006-0081-07", "0006-0081-14" ], "unii": [ "TS63EW8X6F", "786Z46389E" ] } }, { "drugcharacterization": "1", "medicinalproduct": "BYETTA", "drugdosagetext": "UNK", "drugadministrationroute": "058", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "drugstartdateformat": "602", "drugstartdate": "2010", "drugenddateformat": "610", "drugenddate": "201201", "actiondrug": "1", "openfda": { "application_number": [ "NDA021773" ], "brand_name": [ "BYETTA" ], "generic_name": [ "EXENATIDE" ], "manufacturer_name": [ "AstraZeneca Pharmaceuticals LP" ], "product_ndc": [ "0310-6512", "0310-6524" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "SUBCUTANEOUS" ], "substance_name": [ "EXENATIDE" ], "rxcui": [ "847910", "847913", "847915", "847917" ], "spl_id": [ "7333a7dd-9449-4c61-b36d-c5d8d7cc239b" ], "spl_set_id": [ "53d03c03-ebf7-418d-88a8-533eabd2ee4f" ], "package_ndc": [ "0310-6512-01", "0310-6512-85", "0310-6524-01" ], "nui": [ "N0000178480", "M0160181", "N0000020058" ], "pharm_class_epc": [ "GLP-1 Receptor Agonist [EPC]" ], "pharm_class_cs": [ "Glucagon-Like Peptide 1 [CS]" ], "pharm_class_moa": [ "Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]" ], "unii": [ "9P1872D4OL" ] } }, { "drugcharacterization": "1", "medicinalproduct": "ONGLYZA", "drugdosagetext": "UNK", "drugadministrationroute": "048", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "drugstartdateformat": "602", "drugstartdate": "2010", "drugenddateformat": "610", "drugenddate": "201201", "actiondrug": "1" } ] } } ] }